Is immunotherapy at reduced dose and radiotherapy for older patients with locally advanced non-small lung cancer feasible?—a narrative review by the international geriatric radiotherapy group

BACKGROUND AND OBJECTIVE: The standard of care for locally advanced non-small cell lung cancer (NSCLC) is either surgery followed by adjuvant chemotherapy with or without radiotherapy or concurrent chemotherapy and radiotherapy. However, older patients (70 years old or above) with multiple co-morbid...

Descripción completa

Detalles Bibliográficos
Autores principales: Vinh-Hung, Vincent, Gorobets, Olena, Duerinkcx, Andre, Dutta, Suresh, Oboite, Eromosele, Oboite, Joan, Ali, Ahmed, Mazibuko, Thandeka, Karlsson, Ulf, Chi, Alexander, Lehrman, David, Mohammed, Omer Hashim, Mohammadianpanah, Mohammad, Loganadane, Gokoulakrichenane, Migliore, Natalia, Vasileiou, Maria, Nguyen, Nam P., Giap, Huan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552052/
https://www.ncbi.nlm.nih.gov/pubmed/36237270
http://dx.doi.org/10.21037/tcr-22-821

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552052/
https://www.ncbi.nlm.nih.gov/pubmed/36237270
http://dx.doi.org/10.21037/tcr-22-821

Ejemplares similares